Identification of a novel fentanyl analogue: p-hydroxy-butyrylfentanyl.

Clicks: 423
ID: 51814
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #2 of 17 articles by views in drug testing and analysis

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
The use of new psychoactive substances (NPS) has become an important worldwide concern. In particular the use of highly potent fentanyl analogues forms a great health threat to users. In this publication, we detail the characterization of a new fentanyl analogue N-(4-hydroxyphenyl)-N-(1-phenethylpiperidin-4-yl)-butyramide (p-hydroxy-butyrylfentanyl) encountered in drug casework in the Netherlands. Characterization was performed using ultra-high performance liquid chromatography-quadrupole-time-of-flight mass spectrometry (UHPLC-Q-TOF-MS), gas chromatography-mass spectrometry (GC-MS), nuclear magnetic resonance (NMR) spectroscopy, Fourier transform infrared (FTIR) spectroscopy and X-ray fluorescence (XRF).
Reference Key
oldenhof2019identificationdrug Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Sander Oldenhof, Angela Ten Pierick, Jildert Bruinsma, Stephen Eustace, Janneke Hulshof, Jorrit van den Berg, Marnix Hoitink
Are you one of these authors? Claim your profile
Journal drug testing and analysis
Year 2019
DOI
10.1002/dta.2695
URL
Keywords
identification fentanyl new psychoactive substance nps

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.